Caoquan Retatrutide Weight Loss Peptide 99% Retatrutide Raw Materials 1g Tirzepatide TR5 TR10 TR20 TR50

Name: Yuki
Wechat：+852 5341 6086

Whatsapp:+852 5341 6086

Email：bai@tianlei1328.cn

Tirzepatide has been shown to help lose weight in overweight patients. Phase 3 clinical trials are currently underway for weight loss in adults who are overweight, obese, or have weight-related health issues. Tirzepatide has received FDA Fast Track designation to speed up its FDA application for treating adults with obesity, or who are overweight with weight-related health conditions.
In the SURMOUNT-1 clinical trial, the average weight loss with tirzepatide after 72 weeks was 15% for the 5mg dose, 19.5% for the 10mg dose, and 20.9% for the 15mg dose.

tirzepatide is a once-weekly glucose-dependent-stimulating polypeptide (GIP, aka: gastric inhibitory polypeptide) receptor and glucagon-like peptide-1 (GLP-1) receptor dual agonist developed by scientists. ChemicalbookGIP and GLP-1 are both hormones secreted by the gut that promote secretion. tirzepatide combines the effects of two -promoting drugs into a single molecule and represents a new class of drugs for the treatment of type 2 diabetes.

How much weight can you lose in a week with tirzepatide?
Clinical trials have shown that study participants taking a weekly dose of semaglutide had an average reduction in body weight of 5-10 percent.

Description:

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

Product Name Tirzepatide
Purity ≥99%
Colour White Powder
CAS NO. 2023788-19-2
Molecular Formula C225H348N48O68
Molecular Weight 4813.527g/mol
Storage Store in cool and dry places, keep away from strong light.

Packing:

10mg/vial 10vials/box

15mg/vial 10vials/box

20mg/vial 10vials/box

30mg/vial 10vials/box

Company profile



Nanhua District Di Lei Trading Service Department is an enterprise specializing in the export of various chemical products. It has strong economic strength, is equipped with the most advanced production equipment and core technologies in the industry, and is deeply engaged in the research and development of high-quality products. The company has always adhered to the core concept of "Quality First", and is committed to providing high-quality and cost-effective premium products for the global market. We uphold an open and win-win attitude, and are willing to join hands with customers at home and abroad to explore the international market. We sincerely welcome customers to visit our factory for business cooperation and exchanges.